InnaVirVax, a privately‐owned, clinical stage biotechnology company that specialises in the development of cutting-­‐edge, immune-­‐based treatments for major unmet medical needs, announced today that it received the Therapeutic Hope Award from Laurence Tiennot-­‐Herment, Chairman of AFM‐ Téléthon, and Thierry Damerval, Deputy Director General of Inserm, during the celebrations organised to mark the 15th anniversary of the Genopole, the largest French BioPark. © Lionel Antoni